Medlive Technology Co., Ltd.
Símbolo: 2192.HK
HKSE
8.51
HKDPrecio de mercado actual
23.3856
Ratio PER
-0.5721
Ratio PEG
6.19B
Capitalización MRK
- 0.02%
Rendimiento DIV
Medlive Technology Co., Ltd. (2192-HK) Estados Financieros
Balance de situación
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |||
---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 17632.85 | 4400.9 | 4216.9 | 3908.7 | ||||||
balance-sheet.row.short-term-investments | 127.15 | 42.6 | 29.6 | 29.6 | ||||||
balance-sheet.row.net-receivables | 581.29 | 155.9 | 124.2 | 95.9 | ||||||
balance-sheet.row.inventory | 0.62 | 0.1 | 0.2 | 0.1 | ||||||
balance-sheet.row.other-current-assets | 229.63 | 58.3 | 35.4 | 33 | ||||||
balance-sheet.row.total-current-assets | 18279.8 | 4572.6 | 4351.7 | 4013 | ||||||
balance-sheet.row.property-plant-equipment-net | 45.37 | 11.1 | 14.6 | 16.9 | ||||||
balance-sheet.row.goodwill | 726.41 | 192.5 | 111.5 | 69.7 | ||||||
balance-sheet.row.intangible-assets | 152.99 | 66.7 | 24.3 | 9.3 | ||||||
balance-sheet.row.goodwill-and-intangible-assets | 879.4 | 259.3 | 135.9 | 79 | ||||||
balance-sheet.row.long-term-investments | 233.75 | 42.4 | 63.2 | -29.3 | ||||||
balance-sheet.row.tax-assets | 17.98 | 8.5 | 8.3 | 6.3 | ||||||
balance-sheet.row.other-non-current-assets | 96.83 | 0 | 29.6 | 29.6 | ||||||
balance-sheet.row.total-non-current-assets | 1273.32 | 321.2 | 251.5 | 102.6 | ||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | ||||||
balance-sheet.row.total-assets | 19553.12 | 4893.8 | 4603.2 | 4115.6 | ||||||
balance-sheet.row.account-payables | 36.9 | 14.8 | 2.7 | 6.2 | ||||||
balance-sheet.row.short-term-debt | 8.87 | 4.5 | 5.1 | 4.2 | ||||||
balance-sheet.row.tax-payables | 46.5 | 25.7 | 35.2 | 31.6 | ||||||
balance-sheet.row.long-term-debt-total | 15.72 | 3.6 | 6.1 | 9 | ||||||
Deferred Revenue Non Current | -7.54 | -7.5 | 0 | 0 | ||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 10.66 | - | - | - | ||||||
balance-sheet.row.other-current-liab | 770 | 175 | 124.9 | 102.8 | ||||||
balance-sheet.row.total-non-current-liabilities | 168.82 | 58.8 | 38.6 | 30.2 | ||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | ||||||
balance-sheet.row.capital-lease-obligations | 33.45 | 8.2 | 11.3 | 13.2 | ||||||
balance-sheet.row.total-liab | 980.04 | 248.6 | 171.3 | 143.4 | ||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 39 | ||||||
balance-sheet.row.common-stock | 0.18 | 0 | 0 | 0 | ||||||
balance-sheet.row.retained-earnings | 1070.8 | 284.9 | 175.3 | 75.6 | ||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 5901.59 | 4597.3 | 308.1 | -39 | ||||||
balance-sheet.row.other-total-stockholders-equity | 11434.72 | -284.9 | 3917.6 | 3873 | ||||||
balance-sheet.row.total-stockholders-equity | 18407.29 | 4597.4 | 4401 | 3948.7 | ||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 19553.12 | 4893.8 | 4603.2 | 4115.6 | ||||||
balance-sheet.row.minority-interest | 165.8 | 47.8 | 30.9 | 23.5 | ||||||
balance-sheet.row.total-equity | 18573.09 | 4645.2 | 4431.9 | 3972.2 | ||||||
balance-sheet.row.total-liabilities-and-total-equity | 19553.12 | - | - | - | ||||||
Total Investments | 318.26 | 42.4 | 92.8 | 0.3 | ||||||
balance-sheet.row.total-debt | 24.58 | 8.2 | 11.3 | 13.2 | ||||||
balance-sheet.row.net-debt | -17438.47 | -4350.1 | -4176 | -3865.9 |
Estado de tesorería
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |||
---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 242.3 | 242.3 | 135 | 69.9 | ||||||
cash-flows.row.depreciation-and-amortization | 9.21 | 0 | 9 | 6.1 | ||||||
cash-flows.row.deferred-income-tax | -19.3 | 0 | 0 | -13.7 | ||||||
cash-flows.row.stock-based-compensation | 10.41 | 10.4 | 17.2 | 14.3 | ||||||
cash-flows.row.change-in-working-capital | 15.77 | 0 | -9.6 | -27.9 | ||||||
cash-flows.row.account-receivables | -16.32 | 0 | -25.1 | -31.7 | ||||||
cash-flows.row.inventory | 0.1 | 0 | -0.1 | -0.1 | ||||||
cash-flows.row.account-payables | 0.17 | 0 | 25.1 | 31.7 | ||||||
cash-flows.row.other-working-capital | 31.98 | 0 | -9.5 | -27.8 | ||||||
cash-flows.row.other-non-cash-items | -175.83 | -252.7 | -74.5 | -4.4 | ||||||
cash-flows.row.net-cash-provided-by-operating-activities | 101.87 | 0 | 0 | 0 | ||||||
cash-flows.row.investments-in-property-plant-an-equipment | -0.75 | 0 | -7.5 | -2 | ||||||
cash-flows.row.acquisitions-net | -56.39 | 0 | -42.6 | -53 | ||||||
cash-flows.row.purchases-of-investments | -5.65 | 0 | -3579.7 | -5.3 | ||||||
cash-flows.row.sales-maturities-of-investments | 1.58 | 0 | 0.7 | 5.3 | ||||||
cash-flows.row.other-investing-activites | -577.8 | 0 | 43.5 | 4.4 | ||||||
cash-flows.row.net-cash-used-for-investing-activites | -634.95 | 0 | -3585.6 | -50.5 | ||||||
cash-flows.row.debt-repayment | 0 | 0 | -5 | -6.5 | ||||||
cash-flows.row.common-stock-issued | 0 | 0 | 0 | 4033.1 | ||||||
cash-flows.row.common-stock-repurchased | -0.68 | 0 | 5 | 0 | ||||||
cash-flows.row.dividends-paid | -124.69 | 0 | -12.1 | -92 | ||||||
cash-flows.row.other-financing-activites | -7.76 | 0 | -10.2 | -142.6 | ||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | -133.13 | 0 | -22.4 | 3792.1 | ||||||
cash-flows.row.effect-of-forex-changes-on-cash | 63.06 | 0 | 329.9 | -53.9 | ||||||
cash-flows.row.net-change-in-cash | 1308.37 | 0 | -3200.9 | 3732 | ||||||
cash-flows.row.cash-at-end-of-period | 6009.58 | 678.2 | 678.2 | 3879.1 | ||||||
cash-flows.row.cash-at-beginning-of-period | 4701.21 | 678.2 | 3879.1 | 147.1 | ||||||
cash-flows.row.operating-cash-flow | 101.87 | 0 | 77.2 | 44.4 | ||||||
cash-flows.row.capital-expenditure | -0.75 | 0 | -7.5 | -2 | ||||||
cash-flows.row.free-cash-flow | 101.12 | 0 | 69.7 | 42.5 |
Fila de la Cuenta de Resultados
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |||
---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 412 | 412 | 314.1 | 284.4 | ||||||
income-statement-row.row.cost-of-revenue | 160.67 | 160.7 | 101.3 | 83.7 | ||||||
income-statement-row.row.gross-profit | 251.34 | 251.3 | 212.7 | 200.7 | ||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||
income-statement-row.row.research-development | 54.26 | - | - | - | ||||||
income-statement-row.row.selling-general-administrative | 141.3 | - | - | - | ||||||
income-statement-row.row.selling-and-marketing-expenses | 32.78 | - | - | - | ||||||
income-statement-row.row.other-expenses | 0 | -8.9 | -8 | -0.7 | ||||||
income-statement-row.row.operating-expenses | 182.51 | 173.6 | 143.4 | 126.9 | ||||||
income-statement-row.row.cost-and-expenses | 343.18 | 334.2 | 244.7 | 210.7 | ||||||
income-statement-row.row.interest-income | 184.31 | 183.9 | 66.2 | 7.7 | ||||||
income-statement-row.row.interest-expense | 0.22 | 0.4 | 0.5 | 0.5 | ||||||
income-statement-row.row.selling-and-marketing-expenses | 32.78 | - | - | - | ||||||
income-statement-row.row.total-other-income-expensenet | 188 | 188.1 | 0.2 | -0.4 | ||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||
income-statement-row.row.other-operating-expenses | 0 | -8.9 | -8 | -0.7 | ||||||
income-statement-row.row.total-operating-expenses | 188 | 188.1 | 0.2 | -0.4 | ||||||
income-statement-row.row.interest-expense | 0.22 | 0.4 | 0.5 | 0.5 | ||||||
income-statement-row.row.depreciation-and-amortization | 3.91 | 9.4 | 9 | 6.1 | ||||||
income-statement-row.row.ebitda-caps | 69.05 | - | - | - | ||||||
income-statement-row.row.operating-income | 65.14 | 65 | 134.8 | 70.3 | ||||||
income-statement-row.row.income-before-tax | 253.13 | 253.1 | 135 | 69.9 | ||||||
income-statement-row.row.income-tax-expense | 1.37 | 1.4 | 8.6 | 24.7 | ||||||
income-statement-row.row.net-income | 242.3 | 242.3 | 117.3 | 40.6 |
Preguntas frecuentes
Cuánto es Medlive Technology Co., Ltd. (2192.HK) activos totales?
Medlive Technology Co., Ltd. (2192.HK) los activos totales son 4893816000.000.
¿Cuáles son los ingresos anuales de la empresa?
Los ingresos anuales son 238498000.000.
¿Cuál es el margen de beneficios de la empresa?
El margen de beneficios de la empresa es 0.610.
¿Qué es el flujo de caja libre de la empresa?
El flujo de caja libre es 0.138.
¿Cuál es el margen de beneficio neto de la empresa?
El margen de beneficio neto es 0.588.
¿Cuáles son los ingresos totales de la empresa?
Los ingresos totales son 0.158.
¿Qué es Medlive Technology Co., Ltd. (2192.HK) beneficio neto (ingresos netos)?
El beneficio neto (ingresos netos) es 242301000.000.
¿Cuál es la deuda total de la empresa?
La deuda total es 8192000.000.
¿Cuál es la cifra de gastos de explotación?
Los gastos de explotación son 173579000.000.
¿Cuál es la cifra de tesorería de la empresa?
La tesorería de la empresa es 4358255000.000.